Matrilin-3 alleviates extracellular matrix degradation of nucleus pulposus cells via induction of IL-1 receptor antagonist

被引:2
|
作者
Lu, X. -D. [1 ]
Liu, Y. -R. [1 ]
Zhang, Z. -Y. [2 ]
机构
[1] Shanxi Med Univ, Hosp 1, Dept Orthoped, Taiyuan, Peoples R China
[2] Shanxi Med Univ, Hosp 1, Dept Dermatol & STD, Taiyuan, Peoples R China
关键词
Matrilin-3; Nucleus pulposus cells; Intervertebral disc degeneration; Extracellular matrix; IL-1 receptor antagonist; LUMBAR INTERVERTEBRAL DISC; MOLECULAR-BASIS; X COLLAGEN; PROTEIN; EXPRESSION; INTERLEUKIN-1; DEGENERATION; FAMILY;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: The intervertebral disc contains abundant extracellular matrix (ECM) imbued with proteoglycans, collagens, and water. With the development of intervertebral disc degeneration (IVDD), the ECM undergoes changes characterized by loss of water content, proteoglycans, and collagen content. The purpose of this study was to explore the vital role of Matrilin-3, an ECM protein involved in the progress of IVDD. MATERIALS AND METHODS: NP cells were isolated from the patients' disc samples and exposed to recombinant human (rh)-Matrilin-3 protein (MATN3), and IL-1 beta is used as a reducer of nucleus pulposus (NP) cells degeneration. Matrilin-3 and IL-1 receptor antagonist (IL-1Ra) were knocked down by siRNA transfection. Messenger RNA expressions of IL-1Ra, Collagen II, aggrecan, MMP-13, and ADAMTS-5 were determined using Real-Time quantitative Polymerase Chain Reaction (RT-qPCR). Later, the protein levels of IL-Ra, Collagen II, and aggrecan were also detected by Western blot. The IL-1Ra, MMP-13, and ADAMTS-5 dose of the supernatants in the culture medium was determined by enzyme linked immunosorbent assay (ELISA). Finally, immunofluorescence was used to expose the expression of Collagen II, aggrecan, and Collagen X. RESULTS: It was found that the expression of IL-1Ra was markedly increased in the present of MATN3 or IL-1 beta, especially these two at once. Besides, MATN3 could upregulate Collagen II and aggrecan expressions, as well as inhibit the MMP-13 and Collagen X production of NP cells. However, the protective effects of Collagen II and aggrecan were abolished after Matrilin-3 silenced. Furthermore, IL-1 beta downregulated the Collagen II and aggrecan but promoted the MMP-13 and Collagen X levels of NP cells, which were antagonized by the action of MATN3. Surprisingly, silencing of IL-1Ra significantly abolished the MATN3-induced the protective effects of ECM in NP cells. CONCLUSIONS: This study provides a novel viewpoint of Matrilin-3 in the ECM stability of NP due to its ability to activate IL-1Ra. It is considered that MATN3 efficiently protects ECM degeneration of human NP cells related to maintain the content of Collagen II and aggrecan, as well as inflammatory inhibition.
引用
收藏
页码:5231 / 5241
页数:11
相关论文
共 50 条
  • [1] Neuropeptide Y prevents nucleus pulposus cells from cell apoptosis and IL-1β-induced extracellular matrix degradation
    Sun, Kaiqiang
    Zhu, Jian
    Sun, Jingchuan
    Sun, Xiaofei
    Huan, Le
    Zhang, Bin
    Lin, Feng
    Zheng, Bing
    Jiang, Jialin
    Luo, Xi
    Xu, Ximing
    Shi, Jiangang
    CELL CYCLE, 2021, 20 (10) : 960 - 977
  • [2] Downregulation of microRNA-448 inhibits IL-1β-induced cartilage degradation in human chondrocytes via upregulation of matrilin-3
    Yang, Hao
    Wu, Di
    Li, Hua
    Chen, Nan
    Shang, Yongjun
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2018, 23
  • [3] Downregulation of microRNA-448 inhibits IL-1β-induced cartilage degradation in human chondrocytes via upregulation of matrilin-3
    Hao Yang
    Di Wu
    Hua Li
    Nan Chen
    Yongjun Shang
    Cellular & Molecular Biology Letters, 2018, 23
  • [4] Ligustilide alleviated IL-1β induced apoptosis and extracellular matrix degradation of nucleus pulposus cells and attenuates intervertebral disc degeneration in vivo
    Wang, Ke
    Chen, Tingting
    Ying, Xiaozhou
    Zhang, Zengjie
    Shao, Zhenxuan
    Lin, Jialiang
    Xu, Tianzhen
    Chen, Yu
    Wang, Xiangyang
    Chen, Jiaoxiang
    Sheng, Sunren
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 69 : 398 - 407
  • [5] MicroRNA-15b silencing inhibits IL-1β-induced extracellular matrix degradation by targeting SMAD3 in human nucleus pulposus cells
    Kang, Liang
    Yang, Cao
    Yin, Huipeng
    Zhao, Kangcheng
    Liu, Wei
    Hua, Wenbin
    Wang, Kun
    Song, Yu
    Tu, Ji
    Li, Shuai
    Luo, Rongjin
    Zhang, Yukun
    BIOTECHNOLOGY LETTERS, 2017, 39 (04) : 623 - 632
  • [6] MicroRNA-15b silencing inhibits IL-1β-induced extracellular matrix degradation by targeting SMAD3 in human nucleus pulposus cells
    Liang Kang
    Cao Yang
    Huipeng Yin
    Kangcheng Zhao
    Wei Liu
    Wenbin Hua
    Kun Wang
    Yu Song
    Ji Tu
    Shuai Li
    Rongjin Luo
    Yukun Zhang
    Biotechnology Letters, 2017, 39 : 623 - 632
  • [7] Simvastatin Inhibits IL-1β-Induced Apoptosis and Extracellular Matrix Degradation by Suppressing the NF-kB and MAPK Pathways in Nucleus Pulposus Cells
    Ji Tu
    Wentian Li
    Yukun Zhang
    Xinghuo Wu
    Yu Song
    Liang Kang
    Wei Liu
    Kun Wang
    Shuai Li
    Wenbin Hua
    Cao Yang
    Inflammation, 2017, 40 : 725 - 734
  • [8] Matrilin-3 Induction of IL-1 receptor antagonist Is required for up-regulating collagen II and aggrecan and down-regulating ADAMTS-5 gene expression
    Chathuraka T Jayasuriya
    Mary B Goldring
    Richard Terek
    Qian Chen
    Arthritis Research & Therapy, 14
  • [9] Simvastatin Inhibits IL-1β-Induced Apoptosis and Extracellular Matrix Degradation by Suppressing the NF-kB and MAPK Pathways in Nucleus Pulposus Cells
    Tu, Ji
    Li, Wentian
    Zhang, Yukun
    Wu, Xinghuo
    Song, Yu
    Kang, Liang
    Liu, Wei
    Wang, Kun
    Li, Shuai
    Hua, Wenbin
    Yang, Cao
    INFLAMMATION, 2017, 40 (03) : 725 - 734
  • [10] Matrilin-3 Induction of IL-1 receptor antagonist Is required for up-regulating collagen II and aggrecan and down-regulating ADAMTS-5 gene expression
    Jayasuriya, Chathuraka T.
    Goldring, Mary B.
    Terek, Richard
    Chen, Qian
    ARTHRITIS RESEARCH & THERAPY, 2012, 14 (05)